伊梅格林:临床药理学审查
Clémence Chevalier1, Pascale Fouqueray1, Sébastien Bolze2
1Poxel SA, 259/261 Avenue Jean Jaurès, 69007, Lyon, France.
Clinical pharmacokinetics
|September 15, 2023
概括
伊梅格林,一种用于治疗2型糖尿病的新型口服低血糖剂,具有独特的药理动力学特征,受有机阴离子载体的影响. 对于功能障碍,需要调整剂量,但药物相互作用潜力较低.
科学领域:
- 药理学 药理学是指药理学的学科.
- 内分泌学 在内分泌学.
- 药物新陈代谢 药物新陈代谢
背景情况:
- 伊梅格林是治疗2型糖尿病的第一类口服低血糖药.
- 它的目标是线粒体的生物能量,以改善胰岛素抵抗和β细胞功能.
研究的目的:
- 为了审查imeglimin的药理动力学特性.
- 评估其吸收,分布,新陈代谢,分泌和药物相互作用潜力.
主要方法:
- 来自临床前和临床研究的药理动力学数据的审查.
- 分析伊梅格林与有机阴离子载体 (OCT) 和多药物和有毒化合物挤出 (MATE) 载体的相互作用.
- 在特殊人群中的表征 (肝/功能障碍,种族).
主要成果:
- 由于输送体和,伊梅格林的吸收是剂量依赖的.
- 它表现出快速分布,较低的蛋白质结合,主要通过尿液不变的分泌.
- 观察到药物相互作用潜力较低,但功能影响清除,需要在受损患者中调整剂量.
结论:
- 伊梅格林具有独特的药物动力学特征,具有较低的药物相互作用潜力.
- 功能障碍需要调整剂量.
- 进一步了解其药理动力学支持其在2型糖尿病治疗中的治疗用途.
更多相关视频
07:28Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level
Published on: January 24, 2025
397
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
12.9K
相关概念视频
Oral Hypoglycemic Agents: Glinides
183
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
183
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Drug Administration and Therapy Phases: Overview
518
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
518
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Pharmacodynamics: Overview and Principles
1.2K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
1.2K
